Pacific Biosciences Of California (PACB) Notes Payables (2011 - 2023)

Pacific Biosciences Of California's Notes Payables history runs 8 years deep, the most recent figure standing at $500000.0 for Q4 2023.

• In Q4 2023, Notes Payables fell 78.26% year-over-year to $500000.0; the TTM figure through Dec 2023 stood at $500000.0 (down 78.26% YoY), while the FY2023 annual figure was $500000.0, down 78.26% from the prior year.
• Notes Payables was $500000.0 for Q4 2023 at Pacific Biosciences Of California, down from $2.3 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $15.9 million in Q4 2019 to a low of $500000.0 in Q4 2023.
• Historically, Notes Payables has averaged $9.4 million across 4 years, with a median of $14.9 million in 2019.
• The sharpest annual moves came in 2022 and 2023: Notes Payables surged 43.03% in 2022, then plunged 78.26% in 2023.
• A 4-year view of Notes Payables shows it stood at $15.9 million in 2019, then slumped by 89.87% to $1.6 million in 2021, then surged by 43.03% to $2.3 million in 2022, then slumped by 78.26% to $500000.0 in 2023.
• The last three Notes Payables figures came in at $500000.0 (Q4 2023), $2.3 million (Q4 2022), and $1.6 million (Q4 2021), per Business Quant data.